In support for an immunogenic mechanism of tumor reduction in M-ILP, patients whose CD8+ T cells responded strongly to a cocktail of common viral antigens (HCMV/EBV/influenza virus) were significantly more likely to achieve CR. The gene discussed is CD8A; the disease is neoplasm.